Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in the Netherlands

Head and Neck

Volumn 38, Issue , 2016, Pages E1247-E1255

  Timmermans, Adriana J ^a   Van Dijk, Boukje A C ^b,c   Overbeek, Lucy I H ^d   Van Velthuysen, Marie Louise F ^a,d   Van Tinteren, Harm ^a   Hilgers, Frans J M ^a,e,f   Van Den Brekel, Michiel W M ^a,e,f  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Department of Research ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Foundation PALGA (the Nationwide Network and Registry of Histo and Cytopathology in The Netherlands)   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

laryngeal cancer; radiotherapy; survival; total laryngectomy; treatment

Indexed keywords

ADJUVANT RADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NETHERLANDS; OVERALL SURVIVAL; PRIORITY JOURNAL; TREND STUDY; CANCER STAGING; LARYNX TUMOR; MIDDLE AGED; REGISTER; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84940498776     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24200     Document Type: Conference Paper

References (28)

1. [No authors listed]. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al., Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
3. Wolf GT,. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited. Head Neck 2010; 32: 7-14.
4. Forastiere AA, Zhang Q, Weber RS, et al., Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013; 31: 845-852.
5. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-816.
6. Hoffman HT, Porter K, Karnell LH, et al., Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (9 Pt 2 Suppl 111): 1-13.
7. Chen AY, Halpern M,. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1270-1276.
8. Olsen KD,. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010; 32: 1-7.
9. Kaanders JH, Hordijk GJ,; Dutch Cooperative Head and Neck Oncology Group. Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation. Radiother Oncol 2002; 63: 299-307.
10. Tjho-Heslinga RE, Terhaard CH, Schouwenburg P, et al., T3 laryngeal cancer, primary surgery vs planned combined radiotherapy and surgery. Clin Otolaryngol Allied Sci 1993; 18: 536-540.
11. van Dijk BA, Karim-Kos HE, Coebergh JW, Marres HA, de Vries E,. Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer 2013; 134: 674-681.
12. Weber RS, Berkey BA, Forastiere A, et al., Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003; 129: 44-49.
13. Machtay M, Moughan J, Trotti A, et al., Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
14. Theunissen EA, Timmermans AJ, Zuur CL, et al., Total laryngectomy for a dysfunctional larynx after (chemo)radiotherapy. Arch Otolaryngol Head Neck Surg 2012; 138: 548-555.
15. Casparie M, Tiebosch AT, Burger G, et al., Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29: 19-24.
16. World Health Organization. International classification of diseases for oncology. Third ed. First revision., Fritz A, Percy C, Jack A, et al, editors. Geneva: World Health Organization 2000.
17. van Agthoven M, Heule-Dieleman HA, de Boer MF, et al., Evaluating adherence to the Dutch guideline for diagnosis, treatment and follow-up of laryngeal carcinomas. Radiother Oncol 2005; 74: 337-344.
18. Dziegielewski PT, O'Connell DA, Klein M, et al., Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 2012; 41 Suppl 1: S56-S64.
19. Manni JJ, Terhaard CH, de Boer MF, et al., Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg 1992; 164: 682-687.
20. Trotti A, Klotch D, Endicott J, Ridley M, Cantor A,. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial. Head Neck 1998; 20: 119-123.
21. Sant M, Allemani C, Santaquilani M, et al., EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-991.
22. Bourhis J, Overgaard J, Audry H, et al., Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843-854.
23. Janssens GO, Terhaard CH, Doornaert PA, et al., Acute toxicity profile and compliance to accelerated radiotherapy plus carbogen and nicotinamide for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial. Int J Radiat Oncol Biol Phys 2012; 82: 532-538.
24. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES,. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
25. Ganly I, Patel SG, Matsuo J, et al., Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 2009; 31: 1489-1495.
26. de Jong MC, Pramana J, van der Wal JE, et al., CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res 2010; 16: 5329-5338.
27. Egelmeer AG, Velazquez ER, de Jong JM, et al., Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients. Radiother Oncol 2011; 100: 108-115.
28. Sherman EJ, Fisher SG, Kraus DH, et al., TALK score: development and validation of a prognostic model for predicting larynx preservation outcome. Laryngoscope 2012; 122: 1043-1050.